Skip to main content

Table 2 Age distribution among cancer cases eligible for survival analysis, Estonia, 1995–2006

From: Sex differences in cancer survival in Estonia: a population-based study

   No. of cases (%)  
Cancer site Age at diagnosis (years) Men Women p-value*
Mouth, pharynx <45 76 (5) 35 (8) p < 0.001
  45–54 317 (23) 60 (13)  
  55–64 503 (36) 92 (20)  
  65–74 379 (27) 128 (28)  
  ≥75 120 (9) 136 (30)  
Stomach <45 140 (5) 126 (5) p < 0.001
  45–54 377 (13) 248 (10)  
  55–64 756 (26) 440 (18)  
  65–74 1067 (37) 801 (33)  
  ≥75 557 (19) 797 (33)  
Colon <45 54 (3) 73 (3) p < 0.001
  45–54 159 (8) 183 (7)  
  55–64 456 (23) 498 (18)  
  65–74 809 (41) 970 (36)  
  ≥75 496 (25) 988 (36)  
Rectum <45 44 (3) 56 (4) p < 0.001
  45–54 134 (8) 131 (8)  
  55–64 428 (27) 307 (19)  
  65–74 641 (40) 531 (34)  
  ≥75 356 (22) 227 (35)  
Pancreas <45 56 (5) 20 (2) p < 0.001
  45–54 18 (13) 76 (7)  
  55–64 318 (28) 184 (18)  
  65–74 414 (36) 350 (34)  
  ≥75 206 (18) 405 (39)  
Lung <45 132 (2) 43 (3) p < 0.001
  45–54 785 (11) 159 (10)  
  55–64 2131 (31) 334 (20)  
  65–74 2859 (41) 610 (37)  
  ≥75 1041 (15) 501 (30)  
Skin melanoma <45 98 (18) 188 (19) p = 0.076
  45–54 75 (14) 147 (15)  
  55–64 130 (24) 199 (20)  
  65–74 147 (28) 239 (25)  
  ≥75 83 (16) 199 (20)  
Kidney <45 86 (5) 38 (3) p < 0.001
  45–54 286 (18) 130 (11)  
  55–64 472 (29) 302 (25)  
  65–74 544 (34) 433 (36)  
  ≥75 229 (14) 290 (24)  
Bladder <45 45 (3) 18 (3) p < 0.001
  45–54 137 (8) 33 (5)  
  55–64 388 (22) 86 (13)  
  65–74 702 (40) 212 (32)  
  ≥75 488 (28) 310 (47)  
  1. *Chi-squared test.